Biomm SA
BOVESPA:BIOM3

Watchlist Manager
Biomm SA Logo
Biomm SA
BOVESPA:BIOM3
Watchlist
Price: 8.9 BRL -0.56%
Market Cap: 1.1B BRL
Have any thoughts about
Biomm SA?
Write Note

P/E
Price to Earnings

-14.5
Current
-6.4
Median
23.7
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-14.5
=
Market Cap
1.1B BRL
/
Net Income
-78.3m BRL
All Countries
Close
Earnings Growth
BR
Biomm SA
BOVESPA:BIOM3
Average P/E: 56.7
Negative Multiple: -14.5
N/A
US
Abbvie Inc
NYSE:ABBV
63.1
406%
US
Amgen Inc
NASDAQ:AMGN
55.1
74%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -254.8
38%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.7
56%
US
Gilead Sciences Inc
NASDAQ:GILD
102.7
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -490.7 N/A
AU
CSL Ltd
ASX:CSL
36.8
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.8 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -521.3 N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -56.8 N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
N/A
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A

See Also

Discover More